Contract Pharmaceutical Manufacturing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
The global Contract Pharmaceutical Manufacturing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Contract Pharmaceutical Manufacturing market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
The global Contract Pharmaceutical Manufacturing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Contract Pharmaceutical Manufacturing market segmented into
- Big Pharma
- Finished Dosage Formulations
- Big Pharma
- Specialty/Midsize
- Generics
- Others
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Catalent
- DPx
- Lonza
- Piramal Healthcare
- Aenova
- Jubilant
- Famar
- Boehringer Ingelheim
- Fareva Holding
- AbbVie
- Nipro Corp
- Vetter
- Sopharma
- DPT Laboratories
- Recipharm
- NextPharma
- Dishman
- Aesica
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY
2.1 Summary about Contract Pharmaceutical Manufacturing Industry
2.2 Contract Pharmaceutical Manufacturing Market Trends
2.2.1 Contract Pharmaceutical Manufacturing Production & Consumption Trends
2.2.2 Contract Pharmaceutical Manufacturing Demand Structure Trends
2.3 Contract Pharmaceutical Manufacturing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Active Pharmaceutical Ingredients
4.2.2 Finished Dosage Formulations
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Big Pharma
4.3.2 Specialty/Midsize
4.3.3 Generics
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Active Pharmaceutical Ingredients
5.2.2 Finished Dosage Formulations
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Big Pharma
5.3.2 Specialty/Midsize
5.3.3 Generics
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Active Pharmaceutical Ingredients
6.2.2 Finished Dosage Formulations
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Big Pharma
6.3.2 Specialty/Midsize
6.3.3 Generics
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Active Pharmaceutical Ingredients
7.2.2 Finished Dosage Formulations
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Big Pharma
7.3.2 Specialty/Midsize
7.3.3 Generics
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Active Pharmaceutical Ingredients
8.2.2 Finished Dosage Formulations
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Big Pharma
8.3.2 Specialty/Midsize
8.3.3 Generics
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Active Pharmaceutical Ingredients
9.2.2 Finished Dosage Formulations
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Big Pharma
9.3.2 Specialty/Midsize
9.3.3 Generics
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Catalent
10.1.2 DPx
10.1.3 Lonza
10.1.4 Piramal Healthcare
10.1.5 Aenova
10.1.6 Jubilant
10.1.7 Famar
10.1.8 Boehringer Ingelheim
10.1.9 Fareva Holding
10.1.10 AbbVie
10.1.11 Nipro Corp
10.1.12 Vetter
10.1.13 Sopharma
10.1.14 DPT Laboratories
10.1.15 Recipharm
10.1.16 NextPharma
10.1.17 Dishman
10.1.18 Aesica
10.2 Contract Pharmaceutical Manufacturing Sales Date of Major Players (2017-2020e)
10.2.1 Catalent
10.2.2 DPx
10.2.3 Lonza
10.2.4 Piramal Healthcare
10.2.5 Aenova
10.2.6 Jubilant
10.2.7 Famar
10.2.8 Boehringer Ingelheim
10.2.9 Fareva Holding
10.2.10 AbbVie
10.2.11 Nipro Corp
10.2.12 Vetter
10.2.13 Sopharma
10.2.14 DPT Laboratories
10.2.15 Recipharm
10.2.16 NextPharma
10.2.17 Dishman
10.2.18 Aesica
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CONTRACT PHARMACEUTICAL MANUFACTURING INDUSTRY
2.1 Summary about Contract Pharmaceutical Manufacturing Industry
2.2 Contract Pharmaceutical Manufacturing Market Trends
2.2.1 Contract Pharmaceutical Manufacturing Production & Consumption Trends
2.2.2 Contract Pharmaceutical Manufacturing Demand Structure Trends
2.3 Contract Pharmaceutical Manufacturing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Active Pharmaceutical Ingredients
4.2.2 Finished Dosage Formulations
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Big Pharma
4.3.2 Specialty/Midsize
4.3.3 Generics
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Active Pharmaceutical Ingredients
5.2.2 Finished Dosage Formulations
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Big Pharma
5.3.2 Specialty/Midsize
5.3.3 Generics
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Active Pharmaceutical Ingredients
6.2.2 Finished Dosage Formulations
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Big Pharma
6.3.2 Specialty/Midsize
6.3.3 Generics
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Active Pharmaceutical Ingredients
7.2.2 Finished Dosage Formulations
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Big Pharma
7.3.2 Specialty/Midsize
7.3.3 Generics
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Active Pharmaceutical Ingredients
8.2.2 Finished Dosage Formulations
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Big Pharma
8.3.2 Specialty/Midsize
8.3.3 Generics
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Active Pharmaceutical Ingredients
9.2.2 Finished Dosage Formulations
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Big Pharma
9.3.2 Specialty/Midsize
9.3.3 Generics
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Catalent
10.1.2 DPx
10.1.3 Lonza
10.1.4 Piramal Healthcare
10.1.5 Aenova
10.1.6 Jubilant
10.1.7 Famar
10.1.8 Boehringer Ingelheim
10.1.9 Fareva Holding
10.1.10 AbbVie
10.1.11 Nipro Corp
10.1.12 Vetter
10.1.13 Sopharma
10.1.14 DPT Laboratories
10.1.15 Recipharm
10.1.16 NextPharma
10.1.17 Dishman
10.1.18 Aesica
10.2 Contract Pharmaceutical Manufacturing Sales Date of Major Players (2017-2020e)
10.2.1 Catalent
10.2.2 DPx
10.2.3 Lonza
10.2.4 Piramal Healthcare
10.2.5 Aenova
10.2.6 Jubilant
10.2.7 Famar
10.2.8 Boehringer Ingelheim
10.2.9 Fareva Holding
10.2.10 AbbVie
10.2.11 Nipro Corp
10.2.12 Vetter
10.2.13 Sopharma
10.2.14 DPT Laboratories
10.2.15 Recipharm
10.2.16 NextPharma
10.2.17 Dishman
10.2.18 Aesica
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Contract Pharmaceutical Manufacturing Product Type Overview
2.Table Contract Pharmaceutical Manufacturing Product Type Market Share List
3.Table Contract Pharmaceutical Manufacturing Product Type of Major Players
4.Table Brief Introduction of Catalent
5.Table Brief Introduction of DPx
6.Table Brief Introduction of Lonza
7.Table Brief Introduction of Piramal Healthcare
8.Table Brief Introduction of Aenova
9.Table Brief Introduction of Jubilant
10.Table Brief Introduction of Famar
11.Table Brief Introduction of Boehringer Ingelheim
12.Table Brief Introduction of Fareva Holding
13.Table Brief Introduction of AbbVie
14.Table Brief Introduction of Nipro Corp
15.Table Brief Introduction of Vetter
16.Table Brief Introduction of Sopharma
17.Table Brief Introduction of DPT Laboratories
18.Table Brief Introduction of Recipharm
19.Table Brief Introduction of NextPharma
20.Table Brief Introduction of Dishman
21.Table Brief Introduction of Aesica
22.Table Products & Services of Catalent
23.Table Products & Services of DPx
24.Table Products & Services of Lonza
25.Table Products & Services of Piramal Healthcare
26.Table Products & Services of Aenova
27.Table Products & Services of Jubilant
28.Table Products & Services of Famar
29.Table Products & Services of Boehringer Ingelheim
30.Table Products & Services of Fareva Holding
31.Table Products & Services of AbbVie
32.Table Products & Services of Nipro Corp
33.Table Products & Services of Vetter
34.Table Products & Services of Sopharma
35.Table Products & Services of DPT Laboratories
36.Table Products & Services of Recipharm
37.Table Products & Services of NextPharma
38.Table Products & Services of Dishman
39.Table Products & Services of Aesica
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Contract Pharmaceutical Manufacturing Product Type Overview
2.Table Contract Pharmaceutical Manufacturing Product Type Market Share List
3.Table Contract Pharmaceutical Manufacturing Product Type of Major Players
4.Table Brief Introduction of Catalent
5.Table Brief Introduction of DPx
6.Table Brief Introduction of Lonza
7.Table Brief Introduction of Piramal Healthcare
8.Table Brief Introduction of Aenova
9.Table Brief Introduction of Jubilant
10.Table Brief Introduction of Famar
11.Table Brief Introduction of Boehringer Ingelheim
12.Table Brief Introduction of Fareva Holding
13.Table Brief Introduction of AbbVie
14.Table Brief Introduction of Nipro Corp
15.Table Brief Introduction of Vetter
16.Table Brief Introduction of Sopharma
17.Table Brief Introduction of DPT Laboratories
18.Table Brief Introduction of Recipharm
19.Table Brief Introduction of NextPharma
20.Table Brief Introduction of Dishman
21.Table Brief Introduction of Aesica
22.Table Products & Services of Catalent
23.Table Products & Services of DPx
24.Table Products & Services of Lonza
25.Table Products & Services of Piramal Healthcare
26.Table Products & Services of Aenova
27.Table Products & Services of Jubilant
28.Table Products & Services of Famar
29.Table Products & Services of Boehringer Ingelheim
30.Table Products & Services of Fareva Holding
31.Table Products & Services of AbbVie
32.Table Products & Services of Nipro Corp
33.Table Products & Services of Vetter
34.Table Products & Services of Sopharma
35.Table Products & Services of DPT Laboratories
36.Table Products & Services of Recipharm
37.Table Products & Services of NextPharma
38.Table Products & Services of Dishman
39.Table Products & Services of Aesica
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Contract Pharmaceutical Manufacturing Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Contract Pharmaceutical Manufacturing Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Contract Pharmaceutical Manufacturing Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Contract Pharmaceutical Manufacturing Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Contract Pharmaceutical Manufacturing Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Contract Pharmaceutical Manufacturing Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Contract Pharmaceutical Manufacturing Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Contract Pharmaceutical Manufacturing Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Contract Pharmaceutical Manufacturing Sales Revenue (Million USD) of Catalent 2017-2020e
72.Figure Contract Pharmaceutical Manufacturing Sales Revenue (Million USD) of DPx 2017-2020e
73.Fi
1.Figure Global Contract Pharmaceutical Manufacturing Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Contract Pharmaceutical Manufacturing Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Contract Pharmaceutical Manufacturing Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Contract Pharmaceutical Manufacturing Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Contract Pharmaceutical Manufacturing Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Contract Pharmaceutical Manufacturing Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Contract Pharmaceutical Manufacturing Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Active Pharmaceutical Ingredients Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Finished Dosage Formulations Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Big Pharma Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Specialty/Midsize Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Generics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Contract Pharmaceutical Manufacturing Sales Revenue (Million USD) of Catalent 2017-2020e
72.Figure Contract Pharmaceutical Manufacturing Sales Revenue (Million USD) of DPx 2017-2020e
73.Fi
